





Market Maker Surveillance Report. CLBS, ACOR, CBCA, BANC, KBSF, AQMS, Winning Stocks With Lowest Price Friction For Thursday,
February 9, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 5251 companies with "abnormal" market making, 4227 companies with positive Friction Factors and 2167 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Thursday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Caladrius Biosciences Inc. (NASDAQ:CLBS), Acorda Therapeutics, Inc. (NASDAQ:ACOR), CROWN BAUS CAPITAL (OTC:CBCA), Banc of California Inc. (NYSE:BANC), KBS Fashion Group Ltd (NASDAQ:KBSF), Aqua Metals (NASDAQ:AQMS). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction CLBS $0.940 0.20% 50,845 55.08% 25,885 28.04% 24,960 266 ACOR $4.000 0.20% 2,343,159 44.54% 1,718,769 32.67% 624,390 1,561 CBCA $2.050 0.38% 35,799 39.13% 31,217 34.12% 4,582 22 BANC $3.690 0.23% 2,251,704 30.73% 1,539,349 21.01% 712,355 1,931 KBSF $1.610 0.56% 54,201 44.10% 40,913 33.29% 13,288 83 AQMS $4.640 0.41% 1,320,714 37.63% 1,309,939 37.32% 10,775 23Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows CLBS with a dollar gain Thursday of $0.94000 and a Friction Factor of 266 shares. That means that it only took 266 more shares of buying than selling to move CLBS higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
Caladrius Biosciences Inc. (NASDAQ:CLBS) - COMMERCIAL BK SHS.
Acorda Therapeutics, Inc. (NASDAQ:ACOR) - Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops CVT-301 that is in the Phase IIb clinical trial for the treatment of OFF periods in Parkinson s disease; CVT-427, which has completed a Phase I clinical trial to treat migraine; and Ampyra/Dalfampridine that is in the Phase I pharmacokinetic studies for the treatment of chronic post-stroke deficits. Further, it develops Plumiaz, a proprietary nasal spray formulation of diazepam to treat people with epilepsy; Cimaglermin alfa/Neuregulins that has completed a Phase I clinical trial for the treatment of heart failure; Remyelinating Antibodies Program, which is in Phase I clinical trial for the treatment of MS; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury. The company has collaborations and license agreements with Biogen International GmbH; Alkermes plc; Rush-Presbyterian St. Luke's Medical Center; Alkermes, Inc.; SK Biopharmaceuticals Co., Ltd.; Astellas Pharma Europe Ltd.; Canadian Spinal Research Organization; Cambridge Enterprise Limited and King's College London; Mayo Foundation for Education and Research; Paion AG; and Brigham and Women s Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York..
CROWN BAUS CAPITAL (OTC:CBCA) - Capitol Bancorp Ltd. Capital T.
Banc of California Inc. (NYSE:BANC) - .
KBS Fashion Group Ltd (NASDAQ:KBSF) - .
Aqua Metals (NASDAQ:AQMS) - .
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net